Published in

Cell Press, Chemistry and Biology, 3(14), p. 241-242, 2007

DOI: 10.1016/j.chembiol.2007.03.004

Links

Tools

Export citation

Search in Google Scholar

When an Inhibitor Promotes Activity

Journal article published in 2007 by Michel Bouvier ORCID
This paper is made freely available by the publisher.
This paper is made freely available by the publisher.

Full text: Download

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Genetic conformational diseases are often caused by modest mutations in proteins that lead to unnecessary recognition of the mutant protein by the endoplasmic reticulum (ER) quality control system as misfolded. These mutations classically occur outside of the predicted functional domain of the affected proteins such that interventions to allow their release from the quality control system and their targeting to their proper site of action could restore function [2]. Classic examples of such diseases include cystic fibrosis, nephrogenic diabetes insipidus, hypogonadotropic hypogonadism, and various lysosomal storage disorders such as GM2 gangliosidosis, Fabry, Gaucher, and Morquio B diseases.